261 related articles for article (PubMed ID: 26907527)
1. Organoids as Models for Neoplastic Transformation.
Neal JT; Kuo CJ
Annu Rev Pathol; 2016 May; 11():199-220. PubMed ID: 26907527
[TBL] [Abstract][Full Text] [Related]
2. Reconstructing the tumor architecture into organoids.
Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
[TBL] [Abstract][Full Text] [Related]
3. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.
Saglam-Metiner P; Gulce-Iz S; Biray-Avci C
Gene; 2019 Feb; 686():203-212. PubMed ID: 30481551
[TBL] [Abstract][Full Text] [Related]
4. Tumor organoids: From inception to future in cancer research.
Yang L; Yang S; Li X; Li B; Li Y; Zhang X; Ma Y; Peng X; Jin H; Fan Q; Wei S; Liu J; Li H
Cancer Lett; 2019 Jul; 454():120-133. PubMed ID: 30981763
[TBL] [Abstract][Full Text] [Related]
5. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
6. The potential application of organoids in breast cancer research and treatment.
Ebrahimi N; Nasr Esfahani A; Samizade S; Mansouri A; Ghanaatian M; Adelian S; Shadman Manesh V; Hamblin MR
Hum Genet; 2022 Feb; 141(2):193-208. PubMed ID: 34713317
[TBL] [Abstract][Full Text] [Related]
7. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
8. Use of Organoids to Characterize Signaling Pathways in Cancer Initiation.
Oatway C; Hirsch CL; Gregorieff A
Methods Mol Biol; 2018; 1765():315-331. PubMed ID: 29589318
[TBL] [Abstract][Full Text] [Related]
9. Emerging organoid models: leaping forward in cancer research.
Fan H; Demirci U; Chen P
J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
[TBL] [Abstract][Full Text] [Related]
10. Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.
Sachdeva UM; Shimonosono M; Flashner S; Cruz-Acuña R; Gabre JT; Nakagawa H
Cancer Lett; 2021 Jul; 509():39-52. PubMed ID: 33838281
[TBL] [Abstract][Full Text] [Related]
11. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.
Bulin AL; Broekgaarden M; Hasan T
Sci Rep; 2017 Nov; 7(1):16645. PubMed ID: 29192263
[TBL] [Abstract][Full Text] [Related]
13. [Normal organoids and their applications in cancer research].
Delom F; Le Morvan V; Robert J; Fessart D
Bull Cancer; 2022 Jan; 109(1):58-64. PubMed ID: 34903368
[TBL] [Abstract][Full Text] [Related]
14. Tumor organoid models in precision medicine and investigating cancer-stromal interactions.
Xu R; Zhou X; Wang S; Trinkle C
Pharmacol Ther; 2021 Feb; 218():107668. PubMed ID: 32853629
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Transformation of Human-Derived Gastric Organoids.
Bertaux-Skeirik N; Centeno J; Gao J; Gabre J; Zavros Y
Methods Mol Biol; 2019; 1576():205-213. PubMed ID: 27539460
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
17. Organoids technology for advancing the clinical translation of cancer nanomedicine.
Zhao DK; Liang J; Huang XY; Shen S; Wang J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
[TBL] [Abstract][Full Text] [Related]
18. [Spheroids to organoids: Solid cancer models for anticancer drug discovery].
Alzeeb G; Corcos L; Le Jossic-Corcos C
Bull Cancer; 2022 Jan; 109(1):49-57. PubMed ID: 34848046
[TBL] [Abstract][Full Text] [Related]
19. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro.
Skardal A; Devarasetty M; Rodman C; Atala A; Soker S
Ann Biomed Eng; 2015 Oct; 43(10):2361-73. PubMed ID: 25777294
[TBL] [Abstract][Full Text] [Related]
20. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
